Receptor blockade with monoclomal antibodies as anti-cancer therapy
- 31 December 1994
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 64 (1), 127-154
- https://doi.org/10.1016/0163-7258(94)90036-1
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Interference of the IGF system as a strategy to inhibit breast cancer growthBreast Cancer Research and Treatment, 1992
- Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibodyJournal of Cellular Physiology, 1990
- mRNA Expression of Transforming Growth Factor Alpha in Human Breast Carcinomas and Its Activity in Effusions of Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENSAnnual Review of Biochemistry, 1987
- Construction of a Novel Oncogene Based on Synthetic Sequences Encoding Epidermal Growth FactorScience, 1987
- Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell lineBiochemical and Biophysical Research Communications, 1985
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985
- Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.JCI Insight, 1985
- Epidermal growth factor receptors in human breast cancerBreast Cancer Research and Treatment, 1984